Anti Helicobacter pylori IgG and IgA response in patients with gastric cancer and chronic gastritis

Hepato-Gastroenterology

Volumn 55, Issue 82-83, 2008, Pages 807-813

  Manojlovic, Nebojsa ^a   Babic, Dragana ^b   Filipovic Ljeskovic, Ivana ^b   Pilcevic, Dijana ^b  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

Antibody; Gastric cancer; Gastritis; Helicobacter pylori; IgA; IgG

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; CANCER PATIENT; CHRONIC GASTRITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER; STOMACH CARCINOGENESIS;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 44349181991     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Suerbaum S, Michetti P: H. pylori infection. N Engl J Med 2002; 347:1175-1186.
2. Parsonnet J: The incidence of H. pylori infection. Aliment Pharmacol Ther 1995; 9:45-51.
3. Frenck RW, Clemens J: Helicobacter in the developing world. Microbes Infect 2003; 5:705-713.
4. Ernst PB, Peura DA, Crowe SE: The Translation of H. pylori Basic Research to Patient Care. Gastroenterology 2006; 130:188-206.
5. Ernst PB, Gold B: The disease spectrum of H. pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. 54th Edition. Palo Alto, CA: Annual Reviews, 2000; pp.615-640.
6. Uemura N, Okomoto S, Yamamoto S et al: H. pylori infection and the development of gastric cancer. N Engl J Med 2001; 345:784-789.
7. Corea P: Bacterial infection as a cause of cancer. J Natl Cancer Inst 2003; 95:E3.
8. Hansson L, Nyren O, Hsing AW et al: The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335:242-249.
9. Zucca E, Bertoni F, Roggero E et al: Molecular analysis of the progression from Helicobacter pylori- associated chronic gastritis to mucosa - associated lymphoid- tissue lymphoma of the stomach. N Engl J Med 1998; 338:804-810.
10. Fishbach W, Dragosic B, Kolve-Goebeler ME et al: Primary gastric B -cell lymphoma: results of a prospective multicentric study. The German-Austrian gastrointestinal Lymphoma Study Group. Gastroenterology 2000; 119:1191-1202.
11. Ekstom AM, Held M, Hansson LE et al: H. pylori in gastric cancer by CagA immunoblot as a marker of past infection.Gastroenterology 2001; 121:784-791.
12. Keller WC, Michetti P: Vaccination against Helicobacter pylori: an old companion of man. Expert Opin Biol Ther 2001; 1(5):782-795.
13. Manojlovic N, Nikolic Lj, Pilcevic D, Josifovski J, Babic D: Systemic humoral immune response in patients with gastric malignancies and benign gastroduodenal disease. Hepatogastroenterology 2004; 51:282-284.
14. Kreuning J, Lindeman J, Biemond I, Lamers CBHW: Relation between IgG and IgA antibody titers against H. pylori in serum and severity of gastritis in asymptomatic subjects. J Clin Pathol 1994; 47:227-231.
15. Rautelin HI, Oksanen AM, Kartunen RA et al: Association of CagA-positive infection with H. pylori antibodies of IgA class. Ann Med 2000; 32(9):652-659.
16. Yamai Y, Mitsushima T, Ikuma H,Okamoto M, Yoshida H, Kawabe T, Shiratori Y, Saito K, Yokoushi K, Omata M: Weak response to H. pylori antibody is high risk for gastric cancer: a cross sectional study of 10,234 endoscoped Japanese. Scand J Gastroenterol 2002; 37(2):148-153.
17. Aromaa A, Kosunen TU, Knekt P, Maatela J, Teppo L, Heinonen OP, Harkonen M, Hakama MK: Circulating anti-H. pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol 1996; 144(2):142-149.
18. Malfetneiner P, Megraud F, O'Morain C: Guidelines for the management of H. pylori infection. Business briefing: European gastroenterology review 2005.
19. Zuniga-Noriega JR, Bosques-Padilla FJ, Perez-Perez GI et al: Diagnostic utility of invasive test and serology for the diagnosis of H. pylori infection in different clinical presentations. Archive of Medical Research 2006; 37:123-128.
20. Peterson LW, Graham DY: H. pylori. In: Sleisenger and Fordtrans (Eds.). Gastrointestinal and liver disease. 7th Edition. London: Saunders, 2002; pp.732-743.
21. Jaskowski TD, Martins TB, Hill HR, Litwin CM: Immunoglobulin A Antibodies to H. pylori. J Clin Microbiol 1997; 2999-3000.
22. Locatelli A, Catapani WR, Gomes CR Jr, Silva CB, Waisberg J: Detection of anti-H. pylori antibodies in serum and duodenal fluid in peptic gastroduodenal disease. World J Gastroenterol 2004; 10(20):2997-3000.
23. Yamamoto T, Fukudu Y, Mizuta T, Fukada M, Nishigami T, Shimoyama T: Serum anti -H. pylori antibodies and gastritis. J Clin Gastroenterol 1995; 21:164-168.
24. Granberg CA, Mansika O, Lehtonen H et al: Diagnosis of H. pylori infection by using pyloriset EIA-G and EIA-A for detection of serum immunoglobulin G(IgG) and IgA antibodies. J Clin Microbiol 1993; 31:1450-1453.
25. Chen TS, Chang FY, Lee SD: Extending the reading time increases the accuracy of rapid whole blood test for diagnosis of H. pylori infection. J Gastroenterol Hepatol 2001; 16:1341-1345.
26. Hoek FJ, Noach EA, Rauws EAJ, Tytgat GNJ: Evaluation of the performance of commercial kits for detection of H. pylori antibodies in serum. J Clin Microbiol 1992; 30:1525-1528.
27. Talley NJ, Lamber S, Howel H, et al: An evaluation of whole blood testing for H. pylori in general practice. Aliment Pharmacol Ther 1998; 12:641-645.
28. Chen TS, Li FY, Chang FY, Lee SD: Immunoglobulin G Antibody against Helicobacter pylori: Clinical Implication of Levels Found in Serum. Clin and Diagn Lab Immunol 2002:1044-1048.
29. Kato S, Furuyama N, Kyoko O, et al: Long-term follow-up study of setum immunoglobulin G and immunoglobulin A antibodies after H. pylori Eradication. Pediatrics 1999; 104(2):1-5.
30. Janualaityte-Gunter D, Kupcinskas L, Pavilonis A, et al: H. pylori and gastric cancer: a gender related difference. FEMS Immunol Med Microbiol 2005; 44:191-195.
31. Atalay C, Atalay G, Altinok M: Serum H. pylori IgG and IgA levels in patients with gastric cancer. Neoplasma 2003; 50(3):185-190.
32. Helicobacter and cancer collaborative group: Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested with prospective cohorts.Gut 2001; 49:347-353.
33. Nomura A, Stemmerman GN, Choyou PH, et al: H. pylori and gastric carcinoma among Japanese Americans in Hawai. N Engl J Med 1991; 325:1132-1136.
34. Parsonet Jfrieman GD, Orentreich N, et al: H. pylori infection and the risk of gastric carcinoma. Ne Engl J Med 1991; 325:1127-1131.
35. Sipponen P, Kosunen TU, value J, et al: H. pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 1992; 45:319-323.
36. Talley NJ, Newell DG, Ormand JE et al: Serodiagnosis of Helicobacter pylori: comparision of enzyme- linked immunosorbent assays. J Clin Microbiol 1991; 29:1635-1639.
37. Klaamas K, Held M, Wadstrom T et al: IgG immune response to H. pylori antigens in patients with gastric cancer as defined by ELISA and immunobloting. Int J Cancer 1996; 67:1-5.
38. Mattisson A, Tinnert A, Hamlet A et al: Specific Antibodies in Sera and Gastric Aspirates of Symptomatic and Asymptomatic Helicobacter pylori infected subjects. Clin Diagn Lab Immunol 1998; 288-293.
39. Loffeld RJLF, Bibi FM, Werdmuller BFM, Kusters JG, Kuipers EJ: IgG antibody titer against H. pylori correlates with presence of cytotoxin associated gene A-positive H. pylori strains. FEMS Immunol Med Microbiol 2000; 28:139-141.
40. Graham DU, genta RM, Graham DP, Crabtree JE: Serum CagA antibodies in sympomatic subjects and patients with peptic ulcer:lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic H. pylori gastritis. J Clin pathol 1996; 49:829-832.
41. Kolho KL, Korhonen J, Verkasalo M et al: H. pylori serology at diagnosis and follow-up of biopsy-verified infection in children. Scand J Infect Dis 2002; 34:177-182.
42. Hsu PI, Lai KHM, Tseng HH et al: Correlation of Serum Immunoglobulin G H. pylori antibody titers with Histologic and Endoscopic Findings in Patients with Dyspepsia. J Clin Gastroenterol 1997; 25(4):587-591.
43. Moshkowitz M, Konikoff FM, Peled Y et al: High H. pylori numbers are associated with low eradication rate after triple therapy. Gut 1995; 36:845-847.
44. Sheu BS, Yang HB, Su IJ et al: Bacterial density of H. pylori predict the success of triple therapy in bleeding duodenal ulcer. Gastrointest Endosc 1996; 44:683-688.
45. Rathbone BJ, Wyatt JI, Worsley BW, Shires SE, Trejdosiewicz LK, Heatley RV, Losowsky MS: Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut 1986; 27(6):642-647.
46. Goodwin CS, Blincow E, Peterson G, Sanderson C, Cheng W, Marshall B, Warren JR, McCulloch R: Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa. J Infect Dis 1987; 155(3):488-494.
47. Yamamoto T, Fukudu Y, Mizuta T, Fukada M, Nishigami T, Shimoyama T: Serum anti -H. pylori antibodies and gastritis. J Clin Gastroenterol 1995; 21:164-168.
48. Plebani M, Basso D, Cassaro M, Brigato L, Scrigner M, Toma A, Di Mario F, Rugge M: H. pylori serology in patients with chronic gastritis. Am J Gastroenterol 1996; 91(5):954-958.
49. Sheu BS, Shiesh SC, Yang HB, Su IJ, Chen CY, Lin XZ: Implications of H. pylori serological titer for the histological severity of antral gastritis. Endoscopy 1997; 29(1):27-30.
50. Hayashi S, Sugiyama T, Yokota K, Isogai H, Isogai E, Oguma K, Asaka M, Fujii N, Hirai Y: Analysis of immunoglobulin A antibodies to H. pylori in serum and gastric juice in relation to mucosal inflammation. Clin Diagn Lab Immunol 1998; 5(5):617-621.
51. Fox JG, Correa P, Taylor NS, Zavala D, Fontham E, Janney F, Rodriguez E, Hunter F, Diavolitsis S: Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am J Gastroenterol 1989; 84(7):775-781.
52. Sim JG, Kim JC, Seo JK: The value of H. pylori IgG Antibody in estimating the Severity of Gastritis in Children. J Korean Med Sci 1995; 10(5):329-333.
53. Futagami S, Takahashi H, Novose Y, Kobayashi M: Systemic and local immune response against H. pylori urease in patients with chronic gastritis: distinct IgA and IgG productive sites. Gut 1998; 43:168-175.
54. Tulinius H, Ogmundsdottir HM, Kristinsson KG, Sig valdason H, Sigvaldadottir E, Kristjansdottir G, Sigfusson N: H. pylori antibodies and gastric cancer in Iceland - The decline in IgG antibody level is a risk factor. APMIS 2001; 109(12):835-841.
55. Kosunen TU, Seppala K, Sarna S, Aromaa A, Knekt P, Virtamo J, Salomaa-Rasanen A, Rautelin H: Association of H. pylori IgA antibodies with the risk of peptic ulcer disease and gastric cancer. World J Gastroenterol 2005; 11(43):6871-6874.